ALEMBICLTD Stock Overview
Engages in real estate business in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Alembic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹132.14 |
| 52 Week High | ₹169.00 |
| 52 Week Low | ₹77.90 |
| Beta | 1.08 |
| 11 Month Change | -6.14% |
| 3 Month Change | -5.08% |
| 1 Year Change | 65.59% |
| 33 Year Change | 22.18% |
| 5 Year Change | 156.58% |
| Change since IPO | 261.78% |
Recent News & Updates
Shareholder Returns
| ALEMBICLTD | IN Real Estate | IN Market | |
|---|---|---|---|
| 7D | 7.8% | 0.2% | 0.2% |
| 1Y | 65.6% | 50.6% | 34.7% |
Return vs Industry: ALEMBICLTD exceeded the Indian Real Estate industry which returned 54.9% over the past year.
Return vs Market: ALEMBICLTD exceeded the Indian Market which returned 36.8% over the past year.
Price Volatility
| ALEMBICLTD volatility | |
|---|---|
| ALEMBICLTD Average Weekly Movement | 6.2% |
| Real Estate Industry Average Movement | 6.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ALEMBICLTD has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ALEMBICLTD's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1907 | 285 | Malika Amin | www.alembiclimited.com |
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties.
Alembic Limited Fundamentals Summary
| ALEMBICLTD fundamental statistics | |
|---|---|
| Market cap | ₹33.95b |
| Earnings (TTM) | ₹2.80b |
| Revenue (TTM) | ₹1.71b |
12.1x
P/E Ratio19.8x
P/S RatioIs ALEMBICLTD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALEMBICLTD income statement (TTM) | |
|---|---|
| Revenue | ₹1.71b |
| Cost of Revenue | ₹605.15m |
| Gross Profit | ₹1.11b |
| Other Expenses | -₹1.69b |
| Earnings | ₹2.80b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 08, 2024
| Earnings per share (EPS) | 10.91 |
| Gross Margin | 64.70% |
| Net Profit Margin | 163.37% |
| Debt/Equity Ratio | 0.4% |
How did ALEMBICLTD perform over the long term?
See historical performance and comparison